obtained from all participants involved in the study and the work was approved by the Medical Ethics Committee of the Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine. None of these HNC patients received any preoperative cancer treatment and were histologically diagnosed as HNC after operation. Additionally, pathological differentiation and clinical stage were respectively determined according to World Health Organization Classification of Tumors and the TNM classification system of the International Union Against cancer (1988) .
DNA extraction and sequencing
CAFs (HNC tissue derived) were sequenced at the KRAS exon 2 locus. Cells were washed, lysed with lysis buffer containing 25mM NaOH, 0.2mM EDTA, and boiled at 95°C for 30 min. Lysate was treated with 40mM Tris-HCl, 1.8mM EDTA, vortexed, and spun at 14,000 RPM for 15 min. PCR was performed with extracted DNA (forward primer: 5′-GGCCTGCTGAAAATGACTGA-3'; reverse primer:
5′-GTCCTGCACCAGTAATATGC-3′) by using PrimeSTAR HS DNA Polymerase (Takara, Japan), and run on a 3% agarose gel via electrophoresis. DNA was spliced from gel and DNA extracted from gel with GeneElute TM Gel Extraction Kit (Sigma, USA). Samples were distributed to Sangon Biotech (Shanghai, China) for sequencing.
Primary antibodies
The antibodies used in this study were as follows: OPN rabbit polyclonal antibody 
Immunohistochemical analysis
Briefly, paraffin-embedded 3 µm thick sections were deparaffinized, rehydrated, submerged into citric acid buffer for heat-induced antigen retrieval, immersed in 0.3% hydrogen peroxide to block endogenous peroxidase activity, blocked with 3% bovine serum albumin, incubated with primary antibodies at 4°C overnight and developed using the DAKO ChemMate Envision Kit/HRP (Dako-Cytomation, USA). The sections were then counterstained with hematoxylin, dehydrated, cleared and mounted.
The tissues exhibiting brown staining in the cytoplasm, nucleus or membrane were 
Western blot analysis
Cells were harvested at the indicated times and rinsed twice with PBS. Cell extracts were prepared with SDS lysis buffer (Beyotime, China) and centrifuged at 14,000 × g for 10 min at 4°C. In addition, the NE-PER™ Nuclear and Cytoplasmic Extraction 1:1,000), p-p65 (Ser468) antibody (CST, USA; 1:1,000) and p-p65 (Ser536) antibody (CST, USA; 1:1,000). GAPDH (AG0766) antibody (Proteintech, USA; 1:10,000) and H3 histone antibody (Beyotime, China; 1:2,000) were used throughout as loading controls. Secondary antibodies (Sigma, USA; 1:10,000) were labeled with IR Dyes.
Signals were observed using an Odyssey Infrared Imaging System (Biosciences, USA).
ELISA analysis
Culture media of 1×10 6 cells were collected separately after incubation for 72 h and then centrifuged at 10,000 × g for 10 min at 4 . The supernatant OPN and IL-6 concentrations and the plasma OPN and IL-6 levels in patients with HNC were assessed using the Human OPN ELISA kit (Boster, China) and human IL-6 ELISA kit (Boster, China). Moreover, the mouse OPN ELISA kit (Boster, China) was used to measure the plasma OPN level of nude mice. Briefly, 100 µL standard samples and supernatant (both the culture media and plasma were diluted 10 times at first) were added into each microtiter plate well in triplicate and incubated for 90 min at 37 °C.
Then, the liquid in each well was removed and 100 µL biotin-labeled antibody dilution was added into each well directly. After incubation for 60 min at 37 °C, the wells were washed and 100 µL avidin-peroxidase complex (ABC) dilution was added into each well. Thirty minutes later, the wells were washed and colored by incubation with tetramethyl benzidine (TMB) solution at 37 °C. Whereafter, the reactions were 
Plasmid construction
The full-length sequences of OPN gene were amplified using PCR methods by a set of primers (forward primer: 5'-CGCAAATGGGCGGTAGGCGTG-3', reverse primer:
5'-CAGCGGGGCTGCTAAAGCGCATGC-3'). The amplified product of the OPN gene was purified, digested and ligated into the respective BanHI and EcoRI sites in the H102 vector (Obio Technology, China). Two individual constructs containing shRNA for human IL-6 and a negative control (i.e., a scrambled sequence) were purchased from Obio Technology. The sequences were as follows: shIL-6-1, 5'-AGATAGAGCTTCTCTTTCG-3'; shIL-6-2, 5'-CTCAGATTGTTGTTGTTAA-3' and negative control, 5'-TTCTCCGAACGTGTCACGT-3'. The constructs were packaged for viral production as described below.
Lentivirus package and construction of OPN-expressing cell line
The 293T cells were cultured in DMEM medium supplemented with 5% FBS and transfected with 3 µg pLenti-OPN or pLenti-shRNA, 1 µg pCMV-VSV-G, and 3 µg pCMV-Delta8.9 using Lipofectamine 2000 reagent (Invitrogen, USA). After the cells were incubated overnight, the medium was replaced with 10 mL fresh medium. The virus-containing supernatants were collected at 48 and 72 h after transfection and then filtered using a 0.45 µm cellulose acetate filter (Merck Millipore, USA). The virus-containing supernatants were diluted 3 times with serum-free DMEM and polybrene (YEASEN, China) was added into the supernatants at the final concentration of 10 µg/mL to improve the efficiency of infection. The culture medium of tumor cells (at the density of 40%) was exchanged with the virus-containing mixture. After 8 h, the medium was exchanged with fresh DMEM culture medium.
The OPN-expressing cells were selected with 10 µg/mL puromycin (Sigma, USA) for 3 weeks before experiments.
Transfection of small interfering RNAs
To knock down the expression of OPN and STAT3 in tumor cells, two OPN gene-specific short interfering RNAs (siOPN-1 5'-GUGGGAAGGACAGUUAUGA dTdT-3' and siOPN-2 5'-CCACAGUAGACACAUAUGAdTdT-3') and three STAT3
gene-specific short interfering RNAs (siSTAT3-1 5'-AAAUGAAGGUGGUGGAG AAdTdT-3', siSTAT3-2 5'-CAUCUGCCUAGAUCGGCUAdTdT-3' and siSTAT3-3
5'-CCCGUCAACAAAUUAAGAAdTdT-3') were used. For transient transfection, tumor cells at 30% confluence were transfected with siRNAs using Lipofectamine TM 2000 reagent (Invitrogen, USA). The efficiency of OPN and STAT3 knock down was confirmed by Western blot analysis and qPCR after 48 h.
Plate colony formation assay
About 500 plasmid or siRNA-transfected tumor cells were cultured with DMEM supplemented with 10% FBS in 6-well plate for two weeks. Colonies were fixed with 4% paraformaldehyde and stained with crystal violet. The colony formation ability was evaluated according to the size and density of the colonies.
Soft agar colony formation assay
Twenty-four hours after tumor cells transfected with siRNA or plasmid, 3×10 3 cells
were mixed with 1 mL of 0.5% agarose in DMEM with 10% FBS, then seeded on the top of solidified 1% agarose in 6-well plate in triplicates. The gel was covered with 500 µL of DMEM medium after the top layer was solidified, added 100 µL DMEM medium every week to prevent the gel drying. The gels incubated for 3-4 weeks until the colonies formed obviously, then colonies > 0.1 mm in diameter were counter under a microscopic field at 20× magnification. 3 independent experiments were finished in this study.
Transwell migration and invasion assay
The cell migration assay was performed with transwell chamber (pores 0.8 µm, Merck
Millipore, USA), while the cell invasion assay was implemented with Matrigel (BD Biosciences, USA) coated on the upper surface of the transwell chamber (pores 0.8 µm, Merck Millipore, USA). Briefly, tumor cells (3×10 4 cells for migration assay and 5×10 4 cells for invasion assay) in 300 µL serum-free DMEM were placed in the transwell chamber and 700 µL DMEM containing 20% FBS was added into the lower chamber. After incubated for about 24 h, the cells that migrated or invaded through the membrane were fixed with 4% paraformaldehyde and stained with crystal violet.
Cells on the upper surface of the filter were removed by wiping with a small cotton swab. Images were captured of five randomly selected fields of the fixed cells, and the cells were counted using Image J software. All experiments were performed in triplicate.
For the cell migration and invasion assay in co-culture system, the mixed cells (the tumor cells were stably transfected with luciferase cDNA in advance) were resuspended in serum-free DMEM and then cultured in the upper chamber for 24 h.
The cells that migrated or invaded through the membrane were isolated by trypsin digestion method and quantified by measuring luciferase activity using a Luciferase Assay System (Promega Corporation, USA).
ChIP analysis
About 5×10 6 cells were fixed in 1 % formaldehyde for 30 min at room temperature, and then DNA was sheared to an average fragment size of 500 to 1,000 bp by sonication. Subsequently, chromatin was immunoprecipitated with STAT3, p65, Here, 1 % of starting chromatin was used as the input, and then a dilution factor of 100 or 6.644 cycles (log2 of 100) was subtracted from the Ct value of diluted input. The primer pairs used for this analysis are described in supplementary Table S1 .
Tumorigenicity assay in vivo
To evaluated the tumor promoting role of IL-6 in vivo, a HNC xenograft model was implemented in BALB/C nude mice (4-weeks-old). Briefly, CAL-27 cells were pretreated with or without 10 ng/mL rhIL-6 for 72 h. Then, a total of 1×10 6 CAL-27 cells in 100 µL serum-free DMEM were subcutaneously injected into the left and right buttocks. The rhIL-6 group (n=5) was intraperitoneally injected with 100 ng rhIL-6 (in 100 µL PBS) once a day, while the control group (n=5) was intraperitoneally injected with 100 µL PBS. Eighteen days after transplantation, xenografted tumors were collected and the tumor growth curve was plotted.
Experimental metastasis assay
Rca-T cell line was used to establish the HNC experimental metastasis model. Rca-T cells were pretreated with or without 10 ng/mL IL-6 for 72 h. Then, a total number of 1×10 6 Rca-T cells in 200 µL serum-free DMEM were injected intravenously into the lateral tail vein of the 4-week-old athymic mice. The IL-6 group (n=5) was intraperitoneally injected with 100 ng IL-6 (in 100 µL PBS) once a day, while the control group (n=5) was intraperitoneally injected with 100 µL PBS. Two weeks later, the animals were sacrificed and the murine lungs were fixed in neutral-buffered formalin, embedded in paraffin, and cut into 4 µm sections for further experiments. Supplementary Table legends   Table S1 . The primers used for real-time PCR Figure S1 Figure S2 
Supplementary Figure legends

